Olema Pharmaceuticals, Inc. (OLMA) — Dilution Risk Analysis

Current Snapshot

Olema Pharmaceuticals, Inc. (OLMA) has a DilutionWatch score of 26/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
87,497,607 Source
Public Float
59,722,960 Source
Float as % of Outstanding
68.3%

Dilution Risk Score

Score: 26/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 4 3, 8-K 1, 3 3, XBRL 1, SC 13G/A 2.

FormFiledAccession
4 2026-09-02 0001871145-26-000006
8-K 2026-08-13 0001193125-26-347853
3 2026-08-13 0001871145-26-000003
xbrl 2026-08-06 xbrl-2844-xbrl_warrant
SC 13G/A 2026-08-06 0000315066-26-002088
SC 13G/A 2026-07-29 0002012383-26-002839
4 2026-04-29 0002018686-26-000006
3 2026-04-29 0002018686-26-000005
4 2026-03-05 0001749432-26-000004
3 2026-02-17 0002110895-26-000004

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 41 months Source
Three-year share count growth 59.76% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 26/10) Source
Cash Runway
41 months Source
Share Count Growth (3-Year)
59.76% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.